1-4 of 4
Roberta Fasani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Available to Purchase
Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, Francesca Mateo, Paula Martínez-Sanz, Andrea Herencia-Ropero, Andreu Òdena, Pau Clavell-Revelles, Giorgia Casali, Heura Domènech, Laia Monserrat, Dražen Papić, Alba Mas Malavila, Anna Pascual-Reguant, Herena Eixarch, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sara Simonetti, Roberta Fasani, Paolo Nuciforo, Carmen Espejo, Stefan Florian, Miguel Ángel Pujana, Lara Nonell, Joan Seoane, Viia Valge-Archer, Mark J. O’Connor, Juan C. Nieto, Holger Heyn, Judith Balmaña, Alba Llop-Guevara, Violeta Serra
Journal: Cancer Research
Cancer Res (2025) 85 (10): 1888–1908.
https://doi.org/10.1158/0008-5472.CAN-24-2531
Published: 15 May 2025
View articletitled, Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer
Open the PDF for Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract CT161: A homologous recombination repair (HRR) functional assay to stratify patients with metastatic prostate cancer for PARP inhibitor treatment in the TOPARP-B clinical trial

Free
Sara Arce-Gallego, Alba Llop-Guevara, Suzanne Carreira, Nuria Porta, Roberta Fasani, Diletta Bianchini, George Seed, Pasquale Rescigno, Alec Paschalis, Claudia Bertan, Chloe Baker, Jane Goodall, Susana Miranda, Ruth Riisnaes, Ines Figueiredo, Ana Ferreira, Rita Pereira, Bora Gurel, Daniel Nava Rodrigues, Wei Yuan, Jan Rekowski, Emma Hall, Violeta Serra, Johann S. de Bono, Joaquin Mateo
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT161.
https://doi.org/10.1158/1538-7445.AM2021-CT161
Published: 01 July 2021
View articletitled, Abstract CT161: A homologous recombination repair (HRR) functional assay to stratify patients with metastatic prostate cancer for PARP inhibitor treatment in the TOPARP-B clinical trial
Journal Articles

Abstract LB-292: p95HER2-T cell bispecific antibody for breast cancer treatment

Free
Rocío Vicario, Irene Rius Ruiz, Beatriz Morancho, Cristina Bernadó Morales, Sylvia Herter, Anne Freimoser-Grundscholber, Jitka Somandin, Johannes Sam, Oliver Ast, Águeda Martinez Barriocanal, Antonio Luque, Marta Escorihuela, Ismael Varela, Paolo Nuciforo, Roberta Fasani, Vicente Peg, Isabel Rubio, Javier Cortés, Violeta Serra, Santiago Escrivá, Jeff Sperinde, Ahmed Chenna, Weidong Huang, John Winslow, Maurizio Scaltriti, Josep Baselga, Josep Tabernero, Pablo Umaña, Marina Bacac, Cristina Saura, Christian Klein, Joaquín Arribas
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-292.
https://doi.org/10.1158/1538-7445.AM2018-LB-292
Published: 01 July 2018
View articletitled, Abstract LB-292: p95HER2-T cell bispecific antibody for breast cancer treatment
Journal Articles

The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium

Free
Silvia Zecchini, Marco Bianchi, Nicoletta Colombo, Roberta Fasani, Giovanni Goisis, Chiara Casadio, Giuseppe Viale, Jinsong Liu, Meenhard Herlyn, Andrew K. Godwin, Paolo G. Nuciforo, Ugo Cavallaro
Journal: Cancer Research
Cancer Res (2008) 68 (4): 1110–1118.
https://doi.org/10.1158/0008-5472.CAN-07-2897
Published: 15 February 2008
View articletitled, The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium
Open the PDF for The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium in another window
Includes: Supplementary data